Brian Goodman

Brian Goodman is an accomplished professional in the biotechnology sector, holding notable positions such as Partner and Principal at MPM BioImpact and Cofounder and Board Director at ReNAgade Therapeutics. With a strong background in leadership roles, Brian also served as a Member of the Board of Directors at Antiva Biosciences, Inc. and Orna Therapeutics, as well as Cofounder and Chief Business Officer at Aktis Oncology. Brian's academic credentials include a PhD in Biochemistry from Harvard Medical School and a dual degree in Biochemistry and Economics from Brandeis University.